Denigma cartographies changes from the molecular level to whole physiology which occur in defined contrasts such as aging and dietary as well as genetic lifespan-extending interventions:
| ID | name | taxid | reference | pmid | tissue | comparision | start | stop | gender | description |
|---|---|---|---|---|---|---|---|---|---|---|
| 98 | Shift in metabolism towards increasing fatty acid syntheses and breakdown | 7227 | Katewa et al. 2012 | — | muscle | diet | DR (0.5% yeast extract) | AL (5% yeast extract) | female/male | Flies on DR shift their metabolism toward increasing fatty acid synthesis and breakdown, specifically in muscle tissues, which is required for varoius responses to DR [22768842]. |
| 99 | Decreased body fat | 10090 | — | — | — | Diet | DR | AL | — | Body fat decreases upon DR [6608731]. |
| 100 | Increase in steady-state triglyceride content | 7227 | Katewa et al. 2012 | — | — | diet | DR (0.5% yeast extract) | AL (5% yeast extract) | female/male | Flies on DR exhibit an increase in steady-state levels of triglyceride content [22768842]. |
| 102 | Increased fat synthesis and oxidation | 10090 | — | — | — | diet | DR | AL | — | During DR there is an increased fat synthesis and oxidation [19887594]. |
| 104 | Hsp12 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Hsp12 levels [Herbert et al. in press]. |
| 105 | Eno1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Eno1 levels [Herbert et al. in press]. |
| 106 | Hxk1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Hxk1 levels [Herbert et al. in press]. |
| 107 | Rtc3 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Rtc3 levels [Herbert et al. in press]. |
| 108 | Rgil induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Eno1 levels [Herbert et al. in press]. |
| 109 | Sbp1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Sbp1 levels [Herbert et al. in press]. |
| 110 | Yef3 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Yef3 levels [Herbert et al. in press]. |
| 111 | Ctt1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Ctt1 levels [Herbert et al. in press]. |
| 112 | Eno1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Eno1 levels [Herbert et al. in press]. |
| 113 | Fba1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Fba1 levels [Herbert et al. in press]. |
| 114 | Fba1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Fba1 levels [Herbert et al. in press]. |
| 115 | Hsp26 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Hsp26 levels [Herbert et al. in press]. |
| 116 | Hsp31 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Hsp31 levels [Herbert et al. in press]. |
| 117 | Lys9 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Lys9 levels [Herbert et al. in press]. |
| 118 | Rtc3 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Rtc3 levels [Herbert et al. in press]. |
| 119 | Rgi1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Rgi1 levels [Herbert et al. in press]. |
| 120 | Oye2 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Oye2 levels [Herbert et al. in press]. |
| 122 | Lysosomal cholesterol content decreases | 10116 | Fusheng Tang, personal communication | — | liver | age | young | old | — | In rat liver cells, the content of cholesterol in the lysosomal membrane decreases with age in spite of the overall increase of total cellular sterols. |
| 123 | Cellular liver sterol content increases | 10116 | [Fusheng Tang, personal communication | — | liver | age | old | young | — | Overall the total cellular sterol content in liver increases with age [Fusheng Tang, personal communication]. |
| 68 | Increase in upper and central body fat deposition | 9606 | — | 2921472 | — | age | — | — | — | There are progressive trends toward increasing upper and central body fat deposition with age with a postmenopausal acceleration of these trends in women [2921472]. |
| 70 | IGF1 levels decline | 9606 | — | 3322823 | plasma | age | — | — | — | A decline in IGF1 expression occurs with age progression. Levels of circulating IGF1 in humans are low at birth, rise progressively during childhood and peak during midadolescence, and then progressively fall as a function of age. Reduction in levels of circulating IGR1 is related to decreased secretion of growth hormone [3322823]. |
Comment on This Data Unit